Borshchahivsky Chemical and Pharmaceutical Plant to Hold Shareholders' Meeting on April 30

04.04.2026    14:32

JSC “Research and Production Center ”Borshchahivsky Chemical and Pharmaceutical Plant“” will hold its annual shareholders' meeting on April 30, 2026, via remote participation. The agenda includes the approval of the annual financial statements, profit distribution, and operating results for 2025.

Borshchahivsky Chemical and Pharmaceutical Plant is one of Ukraine’s largest pharmaceutical manufacturers and produces a wide range of medicines for the domestic market and export.

According to Opendatabot, Borshchahivsky Chemical and Pharmaceutical Plant increased its revenue by 7.8% in 2025 compared to 2024—to UAH 2.241 billion. It was previously reported that, based on 2024 results, the company increased its net profit by nearly 17% compared to 2023—to UAH 273.4 million.

Currently, the shareholders of BHFZ are PJSC “Pharmaceutical Firm “Darnitsa”” (Kyiv), which owns 31.8% of the shares, as well as “Beldor Group” (21.26%) and “Lenik Group” (20.32%).

The ultimate beneficiaries of the company are Hlib Zagoriy, Yevhen Sova, Tetiana Artemenko, Mykola Bezpalko, and Oleg Goloborodko.

Теги:   shareholders’ meeting Borshchahivsky Chemical and Pharmaceutical Plant Переглядів:   78